Psynary
PHARMACEUTICAL RESEARCH

Digital Endpoints for Clinical Trials

Real-time monitoring of medication efficacy and side effects.

Pharmaceutical research laboratory with scientists

Features Grid

Digital endpoints and real-time monitoring for pharmaceutical clinical trials.

Digital Endpoints

Validated measures of depression & anxiety.

Rapid Non-Response Detection

Within 4–6 days.

Post-Marketing Surveillance

Real-world evidence generation.

Evidence Section

Olanzapine response prediction study and Lithium outcomes audits demonstrate clinical effectiveness.

Digital endpoints for depression and anxiety trials
Real-time medication efficacy and side effect monitoring
Phase IV and post-marketing study support

Medication Effectiveness Tracking

Medication effectiveness interface showing lamotrigine dosage adjustments and outcomes, plus Quetiapine and Lurasidone trials
Dosage OptimizationTreatment Response

Benefits

Reduced Trial Costs

Faster recruitment and early efficacy detection reduce overall costs.

Higher-Quality Regulatory Submissions

Digital endpoints provide robust data for regulatory approval.

Continuous Monitoring Beyond Phase IV

Post-marketing surveillance and real-world evidence generation.

Accelerate Drug Development

Reduce trial timelines, improve data quality, and increase success rates with Psynary's digital clinical trial platform.

50%
Faster Patient Recruitment
Through digital screening and assessment
90%
Data Quality Improvement
Automated collection reduces errors
6 Days
Early Efficacy Detection
Rapid go/no-go decisions

Integrate Psynary into your next trial

Partner with Psynary to accelerate drug development with digital endpoints and real-time patient monitoring.